Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-24

Clinical Trial Update: Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata [Phase 4]

View source ↗

Summary

Phase 4 trial comparing topical minoxidil with a potent topical corticosteroid versus intralesional corticosteroid for alopecia areata. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MINOXIDIL (Minoxidil)
  • Topical corticosteroid (potent)
  • intralesional corticosteroid (corticosteroid)

Snippet

Sponsor: Cairo University | Conditions: Alopecia Areata | Phase 4 | Status: COMPLETED